<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The chromosomal translocation t(8;14)(q24;q32) represents a characteristic marker for Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>This translocation involves the MYC oncogene on chromosome 8 and the immunoglobulin heavy-chain (IgH) locus on chromosome 14 </plain></SENT>
<SENT sid="2" pm="."><plain>Since the translocation does not produce a fusion gene, we established a long-distance polymerase chain reaction (LD-PCR) assay that can detect the t(8;14) at the genomic level </plain></SENT>
<SENT sid="3" pm="."><plain>The sensitivity of the LD-PCR was 10(-4) </plain></SENT>
<SENT sid="4" pm="."><plain>We used the LD-PCR assay to prospectively study 78 BL patients and found a specific PCR product in 52 of them </plain></SENT>
<SENT sid="5" pm="."><plain>Among the 52 positive patients, we could test both the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and the bone marrow (BM) at diagnosis in 33 and determined the prevalence of minimal disseminated disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDD</z:e>) at diagnosis </plain></SENT>
<SENT sid="6" pm="."><plain>In 12/33 patients, BM was positive by LD-PCR and in 10 of them we conducted a study of <z:e sem="disease" ids="C0242596" disease_type="Neoplastic Process" abbrv="MRD">minimal residual disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e>) </plain></SENT>
<SENT sid="7" pm="."><plain>Eight out of 10 children showed a clearance of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> after one cycle of chemotherapy </plain></SENT>
<SENT sid="8" pm="."><plain>The only two patients who did not achieve a negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> status died of disease progression </plain></SENT>
<SENT sid="9" pm="."><plain>The comparative analysis of sensitivity of BM aspirate, BM biopsy and LD-PCR in t(8;14)-positive patients demonstrated a superiority of the molecular method in the assessment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDD</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The LD-PCR for t(8;14) is an important tool to study minimal BM infiltration at diagnosis and to determine its response kinetics in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
</text></document>